Use of Bv8 and/or EG-VEGF to promote hematopoiesis

Details for Australian Patent Application No. 2004219592 (hide)

Owner Genentech, Inc.

Inventors Lecouter, Jennifer; Ferrara, Napoleone

Agent Griffith Hack

Pub. Number AU-B-2004219592

PCT Pub. Number WO2004/081229

Priority 60/454,462 12.03.03 US; 60/511,390 14.10.03 US

Filing date 12 March 2004

Wipo publication date 23 September 2004

Acceptance publication date 29 July 2010

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/081229 Priority application(s): WO2004/081229

29 July 2010 Application Accepted

  Published as AU-B-2004219592

4 November 2010 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 11 Oct 2010. Address for service in Australia - Griffith Hack Level 3 509 St Kilda Road Melbourne VIC 3004

24 February 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 11 Oct 2010

3 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004219595-Formulations for cellschedule dependent anticancer agents

2004219584-Approaches to identifying genetic traits in animals